TIRZEPATIDE (GLP2) 15MG

Overview

Pepnova TIRZEPATIDE (GLP2) 15MG is a specialized, thiozolidine-stabilized analog of Glucagon-Like Peptide-2, engineered for advanced gastrointestinal research. This modified peptide exhibits enhanced stability and a prolonged half-life, making it an exceptional tool for sustained studies on intestinal growth, nutrient absorption, and gut barrier function.

Key Features & Benefits

• Enhanced Stability & Half-Life: The Thiozolidine (TZ) modification significantly increases metabolic stability, allowing for research into prolonged GLP-2 receptor agonism over extended study periods.
• Intestinal Trophic Research: A primary compound for studying the proliferation and repair of intestinal mucosa (enterocytes), villus growth, and crypt depth.
• Gut Barrier Function Studies: Enables investigation into compounds that may enhance intestinal barrier integrity and reduce permeability (“leaky gut” models).
• High-Purity Research Grade: Synthesized to ≥ 99% purity (HPLC verified), ensuring reliable and reproducible experimental outcomes.

Primary Research Applications

• Study of intestinal adaptation, growth, and repair following injury or nutrient deprivation.
• Research into nutrient uptake efficiency and the mechanisms of malabsorption.
• Investigation of gut barrier integrity and its role in systemic inflammatory responses.
• Long-term models examining the effects of sustained GLP-2 receptor activation.

Product Specifications

• Unit Size: 15mg
• Compound: GLP-2 TZ (Thiozolidine-stabilized Glucagon-Like Peptide-2 analog)
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized (freeze-dried) powder
• Storage: For maximum stability, store in a cool, dry place. For long-term storage, refrigeration is recommended

Important Notice

This product is intended for laboratory research and in-vitro study only. It is not for human or veterinary consumption, nor is it a drug or supplement. GLP-2 TZ is a potent peptide for gastrointestinal research and must be handled by qualified professionals using appropriate safety protocols.